Each October, the Nobel Prize announcements remind the world that science, too, has its canons—and its exclusions. This year, a chorus of prominent researchers has broken with tradition by publicly naming what they call manifest injustices in the Swedish Academy's selections, pointing to foundational work in DNA research and the Human Genome Project that has shaped all of modern biology yet remains unrecognized by Stockholm. The challenge is less about any single omission than about a deeper question: whether the criteria governing one of humanity's most consequential honors still reflect the
Top scientists challenge Nobel Prize selection, citing 'manifest injustices' in recognition
Manifest injustices in how science's highest honor is awarded
Mark
So what's actually driving this now? Scientists have always had opinions about who should win the Nobel Prize.
Mimi
The difference is they're saying it out loud together, and they're using the word injustice. That's not academic disagreement—that's a claim about fairness.
Luke
But we should be careful here. The source material is thin on specifics. Which six breakthroughs exactly? Who are the overlooked scientists? We're told there's criticism, but we don't have the actual names or the actual work being excluded.
Mimi
Fair point. But the pattern they're identifying is real—the Human Genome Project was enormous, transformative, and some of its central figures have never won a Nobel. That's documented.
Mark
Why does it matter if they win or not? The work is still done, the science still stands.
Mimi
Because the Nobel Prize is how the world signals what matters. It shapes how funding flows, how careers are built, how history remembers who did what. If the selection process is broken, that's not just about a trophy.
Luke
Right, but we don't actually know if the selection process is broken or if these scientists simply disagree with the committee's judgment. Those are different things. The source doesn't give us the committee's reasoning.
Mark
So what would need to happen for this criticism to actually change anything?
Mimi
Probably sustained pressure, and probably some willingness from the Academy to defend or revise its criteria. But that's speculation on my part.
Luke
And that's the key gap—we know scientists are upset, but we don't know what they're asking for or what would satisfy them. Is it retroactive recognition? Changes to future selection? We're not told.
Le Pouls
- Leading scientists are no longer whispering their frustrations privately—they are naming the Nobel committee's decisions as indefensible, publicly and collectively.
- At least six landmark breakthroughs in DNA and genome science, including contributions central to the Human Genome Project, have been passed over in ways critics describe as obvious rather than debatable.
- The Human Genome Project—completed in 2003, foundational to virtually every advance in genetics since—remains a particular wound, with key architects still holding no Nobel recognition.
- The controversy is forcing a structural question into the open: if the world's most prestigious scientific honor is perceived as systematically blind to certain kinds of work, its authority to define what matters begins to erode.
- The Nobel Committee's historical resistance to outside pressure meets, this year, a scientific community willing to frame its objection not as disagreement but as a failure of justice.
Each October, the Nobel Prize announcements remind the world that science, too, has its canons—and its exclusions. This year, a chorus of prominent researchers has broken with tradition by publicly naming what they call manifest injustices in the Swedish Academy's selections, pointing to foundational work in DNA research and the Human Genome Project that has shaped all of modern biology yet remains unrecognized by Stockholm. The challenge is less about any single omission than about a deeper question: whether the criteria governing one of humanity's most consequential honors still reflect the actual contours of scientific progress.
A growing number of prominent scientists have begun openly challenging the Nobel Prize selection process, arguing that this year's decisions reflect a troubling pattern of exclusion rather than an isolated misstep. Their criticism centers on at least six major breakthroughs in DNA and genome research—work that fundamentally altered how science understands heredity, disease, and the architecture of life—that the Swedish Academy has declined to recognize.
The language being used is striking in its directness. The phrase "manifest injustices" recurs across accounts of the criticism, signaling that those involved do not regard the omissions as subtle or arguable. This represents a shift in how the scientific community relates to institutional authority: less deference, more demand for accountability.
The Human Genome Project sits at the heart of the controversy. Completed in 2003 as one of the largest collaborative scientific endeavors in history, it produced the foundational map of human DNA that has enabled nearly every major genetic advance since. Yet several of its central architects remain without Nobel recognition—a gap that critics now call untenable.
What gives this moment its weight is not simply that scientists disagree with a selection committee, which has always happened, but that they are doing so collectively and framing their objection in the language of justice rather than preference. The Nobel Prize shapes careers, funding, and institutional prestige; if its selection process is seen as outdated or systematically skewed, that perception carries real consequences for the award's authority.
Whether the Academy will respond to this pressure remains uncertain—it has long guarded its independence fiercely. But the willingness of leading researchers to challenge the institution directly suggests the stakes, for the historical record and for fairness, now feel too high to stay silent.
A chorus of prominent scientists has begun openly questioning the Nobel Prize selection process, arguing that the Swedish Academy's decisions this year represent what they characterize as significant oversights in recognizing foundational work in biology and genetics. The criticism centers on the exclusion of multiple landmark contributions to DNA research and the Human Genome Project—discoveries that shaped modern molecular biology but apparently did not meet the committee's threshold for recognition.
The discontent appears to stem from a pattern rather than a single omission. Multiple researchers and commentators have highlighted at least six major breakthroughs in DNA and genome science that, in their view, warranted Nobel consideration but were passed over. These are not marginal contributions or preliminary findings; they represent work that altered how scientists understand heredity, disease, and the fundamental architecture of life itself. The fact that several of these advances remain unrecognized by the Nobel committee raises a harder question: what criteria actually govern the selection, and are those criteria still aligned with the shape of modern science?
The timing of this public challenge is notable. Rather than accepting the Academy's decisions as final, leading figures in the scientific community are now willing to name what they see as injustice. This represents a shift in tone—less deference to institutional authority, more direct accountability. The phrase "manifest injustices" appears in multiple accounts of the criticism, suggesting that the scientists involved believe the oversights are not subtle or debatable but rather obvious and indefensible.
The Human Genome Project itself occupies a particular place in this conversation. Completed in 2003 as one of the largest collaborative scientific efforts in history, it provided the foundational map of human DNA that has enabled virtually every major advance in genetics since. Yet the project's architects and key contributors have not all received equivalent recognition from Stockholm. Some of the scientists most central to that work remain without a Nobel Prize, a gap that critics now argue is untenable.
What makes this moment significant is not merely that scientists disagree with a selection committee—that has always happened. Rather, it is that they are doing so publicly and collectively, and they are framing their objection not as a matter of opinion but as a failure of justice. This language suggests a deeper concern: that the Nobel Prize, as an institution, may no longer be adequately recognizing the full scope of transformative biological research, or that its selection process contains blind spots that systematically exclude certain kinds of work or certain researchers.
The controversy also points to a structural question about how scientific achievement is measured and honored. The Nobel Prize remains one of the most prestigious markers of scientific legitimacy, shaping careers, funding, and institutional prestige. If the selection process is perceived as unfair or outdated, that perception itself becomes consequential—it affects how the scientific community views the award's authority and what it signals about whose work matters.
Whether this public pressure will prompt the Nobel Committee to reconsider its criteria or past decisions remains unclear. The Academy has historically been resistant to external pressure and protective of its independence. But the fact that leading scientists are now willing to challenge the institution directly suggests that the stakes—in terms of recognition, fairness, and the historical record—feel high enough to warrant the risk.
Citations marquantes
Scientists characterize the Nobel Prize selection process as containing manifest injustices— Multiple leading researchers
Envie de l'histoire complète ?
Lire l'original sur Google News ↗
Science & Space